A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...

BOSTON, Nov. 10, 2025 /PRNewswire/ -- Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo during November 11-15 in Boston, presenting its ...

Transposable elements play a significant role in regulating gene expression and genome architecture, influencing development, ...

Prime Medicine, Inc. ( PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease November 12, 2025 8:00 AM EST ...

Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen ...

WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial.

Pluribus season 1 premiered on Apple TV on November 7, 2025. Read on to discover who stars in the show.

Completed enrollment of the randomized Phase 1b cohorts of the ongoing ENABLE trial of ELVN-001 in CML Remains on track to initiate Phase 3 pivotal trial of ELVN-001 ...

The devastating retrovirus HTLV-1 has eluded scientists for decades. Overcoming chronic funding and other challenges, ...

Researchers found that the body’s natural recycling system, the lysosome, plays a vital role in removing the protein that ...

In a world gripped by the challenges of viral outbreaks, the global anti-viral therapies market stands as a beacon of hope. With a valuation of $38,316.5 million in 2018, the mark ...